Vijaya Diagnostic Centre Limited | Globe Capital Market LTD.
Vijaya Diagnostic Centre Limited
Price Band
Rs. 522 – 531
IPO Issue Period
Sep 01, 2021 to Sep 03, 2021
Issue Size
Rs. 1895 Cr.
Face value
Rs. 1/-
Fresh issue
Offer for sale
Rs. 1895 Cr.
Minimum Shares for Retail
Maximum Shares for Retail
Listing on
Issue Type
Book Building
Tentative Listing Date
Not More than 50% of the offer
Not less than 15% of the offer
Not less than 35% of the offer
Registrar to the Issue
KFintech Private Limited

Edelweiss Financial Services Ltd, ICICI Securities Limited, Kotak Mahindra Capital Company Limited

Vijaya Diagnostic Centre is one of the fastest-growing diagnostic chains in Southern India. The company offers a one-stop solution for pathology and radiology testing services. The company offers around 740 routine tests, 870 specialized pathology tests, 220 basic tests, and 320 advanced radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers. Its operational network consists of 80 diagnostic centers and 11 reference laboratories spread across 13 cities and towns in the states of Telangana, Andhra Pradesh, National Capital Region, and Kolkata. During the year ended March 31, 2021, the company conducted approximately 6.20 Mn pathology tests and 0.89 Mn radiology tests for approximately 2.63 Mn customers. As of March 31, 2021, all Vijaya Diagnostic Centre laboratories hold National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditations, and three diagnostic centers hold Patient Safety & Quality of Care (NABH) accreditations. Dr. S. Surendranath Reddy is the promoter of the company.

For year/ period ended ( in Cr.)

31 Mar 2021 31 Mar 2020 31 Mar 2019
Total Revenue 388.5 354.18 302.94
Profit After Tax 84.91 62.5 30.29
EPS 8.26 6.13 4.5
OPM(%) 45.79% 41.78% 39.11%
PATM(%) 21.86% 17.65% 10.00%
  • Largest and fastest-growing diagnostic chain in Southern India & Expand in Adjacent Geographies and East India.
  • Affordable, one-stop solution diagnostics service provider with a focus on superior quality.
  • Strong technical capabilities, cutting-edge diagnostic testing technology and robust IT infrastructure.
  • All laboratories hold National Accreditation.
  • Achieve the benefits of share listing on the Stock Exchanges.
  • To make an offer for sale (OFS) of 35,688,064 shares.

At the upper band of Rs 531, the stock is valued at P/E multiple of 64x, which is richly valued. Hence, investor may consider subscribing for listing gains.

Be a Part of IPO Success Stories!

Never Miss IPO Investment